A non-interventional, multicenter, retrospective chart review study assessing the efficacy of tyrosine kinase inhibitors in patients with newly diagnosed chronic myeloid leukemia
Latest Information Update: 08 Aug 2021
At a glance
- Drugs Dasatinib (Primary) ; Imatinib (Primary) ; Nilotinib (Primary) ; Ponatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 08 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association